Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mulberry leaf (Morus alba) contains 1-deoxynojirimycin (DNJ), which inhibits α-glucosidase enzyme to regulate glucose metabolism and improve insulin sensitivity. The leaves also provide rutin, gallic acid, and other flavonoids that deliver antioxidant protection through free radical scavenging and anti-inflammatory pathways.
Reported Benefits (Provisional)
Origin & History
Mulberry (Morus spp.) is a deciduous fruit tree native to temperate and subtropical regions of Asia, Europe, and North America, particularly thriving in East Asia. The small, sweet-tart berries are available in black, red, and white varieties, and are celebrated for their rich antioxidant and nutrient profile. Both the fruit and leaves have been utilized for centuries in traditional medicine for their diverse health benefits.
Research Narrative (Provisional)
Numerous in vitro, animal, and some human studies support Mulberry fruit's potent antioxidant, immune-boosting, and cardiovascular benefits, particularly due to its anthocyanin and resveratrol content. Research also indicates its potential for blood sugar regulation and skin health. Further robust human clinical trials are needed to fully establish its therapeutic efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary fiber - Natural sugars - Vitamin C - Potassium - Iron - Magnesium - Anthocyanins - Resveratrol - Flavonoids (e.g., quercetin) - 1-deoxynojirimycin (DNJ) - Polysaccharides
Reported Mechanism (Provisional)
1-Deoxynojirimycin (DNJ) inhibits α-glucosidase enzyme, delaying carbohydrate breakdown and improving glucose metabolism. Rutin and other flavonoids scavenge DPPH/ABTS radicals while upregulating antioxidant enzymes like SOD and glutathione peroxidase. Anti-inflammatory effects occur through suppression of TNF-α, IL-6, and NF-κB pathways.
Clinical Narrative (Provisional)
Current evidence is primarily based on in vitro and animal studies, with limited human clinical trial data available. Preclinical research shows DNJ achieves 76% inhibition of melanoma cell proliferation and mulberry proteins enhance B/T cell proliferation at 125-2000 µg/mL concentrations. Studies demonstrate increased SOD/glutathione levels and reduced inflammatory markers in laboratory models. Robust randomized controlled trials in humans are needed to establish definitive therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.